StreetInsider.com News Articles

Form 8-K BeyondSpring Inc. For: Jun 04

Thu, 04 Jun 2026 07:30:00 -0400

si-local-file:///var/storage/secattach/20260604/26602462.html

Form 8-K BeyondSpring Inc. For: Jun 04

Thu, 04 Jun 2026 07:30:00 -0400

si-local-file:///var/storage/secattach/20260604/26602462.html

BeyondSpring names new CEO as founder transitions to chairman role

Thu, 04 Jun 2026 07:01:33 -0400

BeyondSpring Inc. (NASDAQ: BYSI) announced a leadership transition effective July 1, 2026, with founder Dr. Lan Huang moving from CEO to Chairman while maintaining her role as CEO of SEED Therapeutics.

Min Qiu will become CEO with a mandate to execute the company's DUBLIN-4 confirmatory Phase 3 trial for Plinabulin in non-small cell lung cancer. Na Li was appointed Chief Financial Officer, and current director Dr. Jiangwen Majeti was named Vice Chairman.

The DUBLIN-4 trial will enroll 442 patients testing Plinabulin combined with docetaxel in non-squamous EGFR wild-type NSCLC patients who progressed on immune checkpoint inhibitor therapies. The study builds on DUBLIN-3

BeyondSpring names new CEO as founder transitions to chairman role

Thu, 04 Jun 2026 07:01:33 -0400

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Thu, 04 Jun 2026 07:00:00 -0400

Dr. Lan Huang, PhD, remains Chairman of BeyondSpring, committing her time to SEED Therapeutics, where she serves as Co-Founder, Chairman, and Chief Executive Officer — a structure designed to give each company a fully dedicated executive leader
Dr. Jiangwen (Jen) Majeti, PhD, MBA, current BeyondSpring Director, appointed Vice Chairman — deepening Board-level governance and providing strategic continuity
Min Qiu appointed Chief Executive Officer with a clear mandate: execute DUBLIN-4, extend Plinabulin’s scientific optionality, and build BeyondSpring’s global partner and investor base
Na Li appointed Chief Financial Officer to strengthen BeyondSpring’s financial position and support capital markets engagement with